JP2022512667A5 - - Google Patents
Info
- Publication number
- JP2022512667A5 JP2022512667A5 JP2021519805A JP2021519805A JP2022512667A5 JP 2022512667 A5 JP2022512667 A5 JP 2022512667A5 JP 2021519805 A JP2021519805 A JP 2021519805A JP 2021519805 A JP2021519805 A JP 2021519805A JP 2022512667 A5 JP2022512667 A5 JP 2022512667A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- gene therapy
- promoter
- therapy vector
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862743623P | 2018-10-10 | 2018-10-10 | |
| US62/743,623 | 2018-10-10 | ||
| PCT/US2019/055635 WO2020077091A1 (en) | 2018-10-10 | 2019-10-10 | Kir 7.1 gene therapy vectors and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512667A JP2022512667A (ja) | 2022-02-07 |
| JP2022512667A5 true JP2022512667A5 (https=) | 2022-11-09 |
Family
ID=70164038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519805A Pending JP2022512667A (ja) | 2018-10-10 | 2019-10-10 | Ｋｉｒ７．１遺伝子療法ベクターおよびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210348196A1 (https=) |
| EP (1) | EP3864160A4 (https=) |
| JP (1) | JP2022512667A (https=) |
| CN (1) | CN113227386A (https=) |
| AU (1) | AU2019357602A1 (https=) |
| CA (1) | CA3115782A1 (https=) |
| IL (1) | IL282181A (https=) |
| JO (1) | JOP20210067A1 (https=) |
| WO (1) | WO2020077091A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230108025A1 (en) * | 2020-03-13 | 2023-04-06 | Wisconsin Alumni Research Foundation | Kir 7.1 gene therapy vectors and methods of using the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0922763A1 (en) * | 1997-12-12 | 1999-06-16 | Synthelabo | Inwardly rectifying potassium channel gene and protein |
| US6399761B1 (en) * | 1998-08-07 | 2002-06-04 | Icagen, Inc. | Nucleic acid encoding human potassium channel K+ nov1 protein |
| WO2011068801A2 (en) * | 2009-12-01 | 2011-06-09 | The Rockefeller University | Methods for identifying compounds that modulate ion channel activity of a kir channel |
| US9567376B2 (en) * | 2013-02-08 | 2017-02-14 | The Trustees Of The University Of Pennsylvania | Enhanced AAV-mediated gene transfer for retinal therapies |
| AU2014305218B2 (en) * | 2013-08-05 | 2020-01-16 | Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum | Recombinant AAV-Crumbs homologue composition and methods for treating LCA-8 and progressive RP |
| LT3137497T (lt) * | 2014-05-02 | 2021-07-26 | Genzyme Corporation | Aav vektoriai, skirti tinklainės ir cns genų terapijai |
| GB201519086D0 (en) * | 2015-10-28 | 2015-12-09 | Syncona Partners Llp | Gene Therapy |
| US11364308B2 (en) * | 2016-05-13 | 2022-06-21 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and methods of use thereof |
| JP7086928B2 (ja) * | 2016-07-25 | 2022-06-20 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 改変されたナチュラルキラー細胞を生成する方法および使用方法 |
-
2019
- 2019-10-10 WO PCT/US2019/055635 patent/WO2020077091A1/en not_active Ceased
- 2019-10-10 JP JP2021519805A patent/JP2022512667A/ja active Pending
- 2019-10-10 EP EP19870458.7A patent/EP3864160A4/en active Pending
- 2019-10-10 CN CN201980081804.XA patent/CN113227386A/zh active Pending
- 2019-10-10 AU AU2019357602A patent/AU2019357602A1/en not_active Abandoned
- 2019-10-10 US US17/284,408 patent/US20210348196A1/en active Pending
- 2019-10-10 CA CA3115782A patent/CA3115782A1/en active Pending
-
2021
- 2021-04-08 JO JOP/2021/0067A patent/JOP20210067A1/ar unknown
- 2021-04-08 IL IL282181A patent/IL282181A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230287401A1 (en) | Rna guided compositions for preventing and treating hepatitis b virus infections | |
| JP2026070504A (ja) | 修飾筋肉標的化組成物 | |
| CA2967990C (en) | Rna guided eradication of human jc virus and other polyomaviruses | |
| AU2017211062A1 (en) | Methods and compositions for RNA-guided treatment of HIV infection | |
| US20190038770A1 (en) | Rna guided eradication of human jc virus and other polyomaviruses | |
| AU2016366229A1 (en) | Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppresive therapy | |
| JP2022126804A5 (https=) | ||
| US20250099554A1 (en) | Compositions and methods of fas inhibition | |
| JP2011511090A5 (https=) | ||
| US12281309B1 (en) | Composition for regulating production of interfering ribonucleic acid | |
| JP2023545229A5 (https=) | ||
| JP2020505390A (ja) | Ｃｒｉｓｐｒ治療薬を送達するためのウイルスベクターとしてのレンチウイルスおよび非組み込みレンチウイルス | |
| JP2021525531A5 (https=) | ||
| JP2019517465A (ja) | 溶菌および溶原ウイルスの処理の組成物および方法 | |
| JP2025513072A5 (https=) | ||
| Saraswat et al. | DNA as therapeutics; an update | |
| JP2022512667A5 (https=) | ||
| Çiçek et al. | Advances in CRISPR/Cas9 technology for in vivo translation | |
| US12162927B1 (en) | Compositions and methods for regulating production of an antibody like protein and ribonucleic acid | |
| JP2023510186A5 (https=) | ||
| JP2022523050A5 (https=) | ||
| TW202405180A (zh) | 用於將核酸遞送至視網膜細胞的腺相關病毒載體 | |
| EP2383286A1 (en) | Methods and compositions for treatment of retinal degenerative diseases | |
| Haritha et al. | Gene therapy–A review | |
| Singh | Role of gene therapy in treatment of cancer for craniofacial regeneration—current molecular strategies, future perspectives, and challenges: a narrative review |